Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 142 No. 4748 (2012)

Vitamin D levels and associated factors: a population-based study in Switzerland

  • Idris Guessous
  • Vincent Dudler
  • Nicolas Glatz
  • Jean-Marc Theler
  • Otmar Zoller
  • Fred Paccaud
  • Michel Burnier
  • Murielle Bochud
DOI
https://doi.org/10.4414/smw.2012.13719
Cite this as:
Swiss Med Wkly. 2012;142:w13719
Published
18.11.2012

Summary

QUESTIONS UNDER STUDY: To update the prevalence of vitamin D insufficiency and to identify factors associated with vitamin D status in the Swiss adult population.

METHODS: Data from the 2010–2011 Swiss Study on Salt intake, a population-based study in the Swiss population, was used. Vitamin D concentration in serum was measured by liquid chromatography- tandem mass spectrometry. Major factors that influence vitamin D levels were taken into account. Survey statistical procedures were used to estimate means and prevalences of vitamin D levels and status. Monthly-specific tertiles of vitamin D and ordinal logistic regression were used to determine the associations of covariates of interest with vitamin D status.

RESULTS: The prevalences of vitamin D insufficiency (serum 25-hydroxyvitamin D: 20–29.9 ng/ml) and deficiency (<20 ng/ml) were the highest in the January-March period; 26.4% (95%CI: 21.6–31.7) and 61.6% (95%CI: 56.0–67.0), respectively. In the same period, more than 9 of ten men were vitamin D insufficient or deficient. Each unit increase of Body Mass Index was associated with an 8% decreased likelihood of being in a higher vitamin D tertiles. Oral contraceptive, altitude, urinary excretion of calcium, use of vitamin D supplement or treatment, high wine consumption, physical activity were associated with vitamin D tertiles. Compared to the French-speaking region, the Italian-speaking region was independantly associated with a higher likelihood of being in higher vitamin D tertiles (OR: 1.66, 95%CI: 1.14–2.43).

CONCLUSIONS: Low levels of vitamin D are common among Swiss adults, in particular during winter months and outside the Italian-speaking region.

References

  1. Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005;98(10):1024–7.
  2. Holick MF. The vitamin D epidemic and its health consequences. J Nutr. 2005;135(11):2739S–48S.
  3. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.
  4. Guessous I, Bochud M, Bonny O, Burnier M. Calcium, vitamin D and cardiovascular disease. Kidney Blood Press Res. 2011;34(6):404–17.
  5. Penckofer S, Kouba J, Wallis DE, Emanuele MA. Vitamin D and diabetes: let the sunshine in. Diabetes Educ. 2008;34(6):939–40.
  6. Holick MF. Diabetes and the vitamin d connection. Curr Diab Rep. 2008;8(5):393–8.
  7. Bertone-Johnson ER. Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev. 2009;67(8):481–92.
  8. Holick MF. Evolution, biologic functions, and recommended dietary allowance for vitamin D. Vitamin D: physiology, molecular biology and clinical applications. New Jersey: Human Press; 1999. p. 1–16.
  9. U.S. Department of Agriculture ARS. USDA National Nutrient Database for Standard Reference. 2011, [cited 2012 October 08]. Available from: http://www.ars.usda.gov/ba/bhnrc/ndl.
  10. Holick MF. Vitamin D: a millenium perspective. J Cell Biochem. 2003;88(2):296–307.
  11. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011;364(3):248–54.
  12. van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25(4):671–80.
  13. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–6S.
  14. Burnand B, Sloutskis D, Gianoli F, Cornuz J, Rickenbach M, Paccaud F, et al. Serum 25-hydroxyvitamin D: distribution and determinants in the Swiss population. Am J Clin Nutr. 1992;56(3):537–42.
  15. Chappuis A, Bochud M, Glatz N, Vuistiner P, Paccaud F, Burnier M. Swiss survey on salt intake: main results. 2011 [cited 2012 Jun 03]. Available from: http://www.bag.admin.ch/themen/ernaehrung_bewegung/05190/05294/12869/index.html.
  16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
  17. Yetley EA, Pfeiffer CM, Schleicher RL, Phinney KW, Lacher DA, Christakos S, et al. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr. 2010;140(11):2030S–45S.
  18. de la Hunty A, Wallace AM, Gibson S, Viljakainen H, Lamberg-Allardt C, Ashwell M. UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr. 104(4):612–9.
  19. National Institute of Standards and Technology. Certificate of analysis, standard reference material 972, vitamin D in human serum. Gaithersburg (MD): NIST; 2009 [cited 2012 Jun 03]. Available from: https://www-s.nist.gov/srmors/certificates/972.pdf.
  20. Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol. 2005;25:39–46.
  21. Burri J, Haldimann M, Dudler V. Selenium status of the Swiss population: assessment and change over a decade. J Trace Elem Med Biol. 2008;22(2):112–9.
  22. Heeringa S, West B, Berglund P. Applied Survey Data Analysis. Sciences SitSaB, editor: Chapman & Hall/CRC; 2010.
  23. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8.
  24. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, Calle EE, et al. Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. Am J Epidemiol. 2009;170(1):88–94.
  25. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metabo. 2011;96(1):53–8.
  26. Nutrition FFCf. Vitamin D deficiency: evidence, safety and recommendations for the Swiss population – summary. 2012 [cited 2012 October 08]. Available from: http://www.bag.admin.ch/themen/ernaehrung_bewegung/05207/13246/index.html?lang=en.
  27. Kimlin MG. Geographic location and vitamin D synthesis. Mol Aspects Med. 2008;29(6):453–61.
  28. Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond). 2012;36(3):387–96.
  29. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–3.
  30. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88(6):1519–27.
  31. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 2009;20(1):133–40.
  32. Scragg R, Thadhani R, Camargo CA, Jr. Association between altitude and mortality in incident dialysis patients. JAMA. 2009;301(23):2442–3.
  33. Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res. 2007;22(Suppl 2):V28–33.
  34. Harris SS, Dawson-Hughes B. The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J Am Coll Nutr. 1998;17(3):282–4.
  35. Aarskog D, Aksnes L, Markestad T, Rodland O. Effect of estrogen on vitamin D metabolism in tall girls. J Clin Endocrinol Metab. 1983;57(6):1155–8.
  36. Wietzke JA, Welsh J. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. J Steroid Biochem Mol Biol. 2003;84(2–3):149–57.
  37. Wollin SD, Jones PJ. Alcohol, red wine and cardiovascular disease. J Nutr. 2001;131(5):1401–4.
  38. Looker AC, Lacher DA, Pfeiffer CM, Schleicher RL, Picciano MF, Yetley EA. Data advisory with regard to NHANES serum 25-hydroxyvitamin D data. Am J Clin Nutr. 2009.
  39. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982;1(8263):74–6.

Most read articles by the same author(s)

<< < 1 2 3 > >>